| 1QUB | A:186-241; A:186-241; A:186-241; A:186-241 | CRYSTAL STRUCTURE OF THE GLYCOSYLATED FIVE-DOMAIN HUMAN BETA2-GLYCOPROTEIN I PURIFIED FROM BLOOD PLASMA |
| 1MD7 | A:359-430 | MONOMERIC STRUCTURE OF THE ZYMOGEN OF COMPLEMENT PROTEASE C1R |
| 1MD8 | A:359-430 | MONOMERIC STRUCTURE OF THE ACTIVE CATALYTIC DOMAIN OF COMPLEMENT PROTEASE C1R |
| 2QY0 | C:359-430; C:359-430; C:359-430; C:359-430 | ACTIVE DIMERIC STRUCTURE OF THE CATALYTIC DOMAIN OF C1R REVEALS ENZYME-PRODUCT LIKE CONTACTS |
| 2OK5 | A:140-193; A:140-193; A:140-193 | HUMAN COMPLEMENT FACTOR B |
| 2XWB | H:140-193; H:140-193; H:140-193; H:140-193; H:140-193; H:140-193 | CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTORS B AND D |
| 2XWJ | L:140-193; L:140-193; L:140-193; L:140-193; L:140-193; L:140-193; L:140-193; L:140-193; L:140-193; L:140-193; L:140-193; L:140-193 | CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B |
| 2JGW | A:386-442; A:386-442 | STRUCTURE OF CCP MODULE 7 OF COMPLEMENT FACTOR H - THE AMD AT RISK VARIENT (402H) |
| 2JGX | A:386-442; A:386-442 | STRUCTURE OF CCP MODULE 7 OF COMPLEMENT FACTOR H - THE AMD NOT AT RISK VARIENT (402Y) |
| 2KMS | A:691-744 | COMBINED HIGH- AND LOW-RESOLUTION TECHNIQUES REVEAL COMPACT STRUCTURE IN CENTRAL PORTION OF FACTOR H DESPITE LONG INTER-MODULAR LINKERS |
| 2V8E | A:448-505; A:448-505; A:448-505 | CRYSTAL STRUCTURE OF HUMAN COMPLEMENT FACTOR H, SCR DOMAINS 6-8 (H402 RISK VARIANT), IN COMPLEX WITH LIGAND. |
| 2W81 | E:385-442; E:385-442; E:385-442; E:385-442; E:385-442; E:385-442 | STRUCTURE OF A COMPLEX BETWEEN NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN AND CCPS 6-7 OF HUMAN COMPLEMENT FACTOR H |
| 2WII | C:192-244; C:192-244; C:192-244; C:192-244 | COMPLEMENT C3B IN COMPLEX WITH FACTOR H DOMAINS 1-4 |
| 2XQW | C:1167-1228; C:1167-1228 | STRUCTURE OF FACTOR H DOMAINS 19-20 IN COMPLEX WITH COMPLEMENT C3D |
| 3KXV | A:1167-1228; A:1167-1228 | STRUCTURE OF COMPLEMENT FACTOR H VARIANT Q1139A |
| 3KZJ | A:1167-1228; A:1167-1228 | STRUCTURE OF COMPLEMENT FACTOR H VARIANT R1203A |
| 3R62 | B:1167-1228; B:1167-1228; B:1167-1228; B:1167-1228 | STRUCTURE OF COMPLEMENT REGULATOR FACTOR H MUTANT, T1184R. |
| 1PPQ | A:963-1020 | NMR STRUCTURE OF 16TH MODULE OF IMMUNE ADHERENCE RECEPTOR, CR1 (CD35) |
| 1LY2 | A:71-126; A:71-126 | CRYSTAL STRUCTURE OF UNLIGANDED HUMAN CD21 SCR1-SCR2 (COMPLEMENT RECEPTOR TYPE 2) |
| 3OED | D:71-126; D:71-126; D:71-126; D:71-126 | THE STRUCTURE OF THE COMPLEX BETWEEN COMPLEMENT RECEPTOR CR2 AND ITS LIGAND COMPLEMENT FRAGMENT C3D |
| 1NWV | A:129-186; A:129-186 | SOLUTION STRUCTURE OF A FUNCTIONALLY ACTIVE COMPONENT OF DECAY ACCELERATING FACTOR |
| 1OJV | B:193-251; B:193-251; B:193-251; B:193-251; B:193-251; B:193-251; B:193-251; B:193-251 | DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR. |
| 1OJW | B:193-251; B:193-251; B:193-251; B:193-251; B:193-251; B:193-251; B:193-251; B:193-251 | DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR. |
| 1OJY | D:193-251; D:193-251; D:193-251; D:193-251; D:193-251; D:193-251; D:193-251; D:193-251; D:193-251; D:193-251; D:193-251; D:193-251; D:193-251; D:193-251; D:193-251; D:193-251 | DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR. |
| 1OK1 | B:193-251; B:193-251; B:193-251; B:193-251; B:193-251; B:193-251; B:193-251; B:193-251 | DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR. |
| 1OK2 | B:193-251; B:193-251; B:193-251; B:193-251; B:193-251; B:193-251; B:193-251; B:193-251 | DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR. |
| 1OK3 | B:193-251; B:193-251; B:193-251; B:193-251; B:193-251; B:193-251; B:193-251; B:193-251 | DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR. |
| 1OK9 | B:193-251; B:193-251; B:193-251; B:193-251; B:193-251; B:193-251; B:193-251; B:193-251 | DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR. |
| 1UOT | P:69-127; P:69-127 | HUMAN CD55 DOMAINS 3 & 4 |
| 1UPN | E:69-127; E:69-127 | COMPLEX OF ECHOVIRUS TYPE 12 WITH DOMAINS 3 AND 4 OF ITS RECEPTOR DECAY ACCELERATING FACTOR (CD55) BY CRYO ELECTRON MICROSCOPY AT 16 A |
| 2QZD | A:1193-1251 | FITTED STRUCTURE OF SCR4 OF DAF INTO CRYOEM DENSITY |
| 2QZF | A:1004-1062 | SCR1 OF DAF FROM 1OJV FITTED INTO CRYOEM DENSITY |
| 2QZH | A:1129-1186; A:1129-1186 | SCR2/3 OF DAF FROM THE NMR STRUCTURE 1NWV FITTED INTO A CRYOEM RECONSTRUCTION OF CVB3-RD COMPLEXED WITH DAF |
| 1Z92 | B:104-163; B:104-163 | STRUCTURE OF INTERLEUKIN-2 WITH ITS ALPHA RECEPTOR |
| 3NFP | K:104-161; K:104-161; K:104-161; K:104-161 | CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN |
| 1Q3X | B:366-430; B:366-430 | CRYSTAL STRUCTURE OF THE CATALYTIC REGION OF HUMAN MASP-2 |
| 1ZJK | A:366-430; A:366-430 | CRYSTAL STRUCTURE OF THE ZYMOGEN CATALYTIC REGION OF HUMAN MASP-2 |
| 2O39 | D:65-123; D:65-123; D:65-123; D:65-123 | HUMAN ADENOVIRUS TYPE 11 KNOB IN COMPLEX WITH DOMAINS SCR1 AND SCR2 OF CD46 (MEMBRANE COFACTOR PROTEIN, MCP) |
| 3L89 | X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123; X:65-123 | HUMAN ADENOVIRUS TYPE 21 KNOB IN COMPLEX WITH DOMAINS SCR1 AND SCR2 OF CD46 (MEMBRANE COFACTOR PROTEIN, MCP) |
| 3O8E | D:194-249; D:194-249; D:194-249; D:194-249; D:194-249; D:194-249; D:194-249; D:194-249 | STRUCTURE OF EXTRACELLLAR PORTION OF CD46 IN COMPLEX WITH ADENOVIRUS TYPE 11 KNOB |
| 3OXU | F:1167-1228; F:1167-1228; F:1167-1228; F:1167-1228; F:1167-1228; F:1167-1228 | COMPLEMENT COMPONENTS FACTOR H CCP19-20 AND C3D IN COMPLEX |
| 2YRA | A:745-800 | SOLUTION STRUCTURE OF THE ZINC FINGER DOMAINS (1-87) FROM HUMAN F-BOX ONLY PROTEIN |
)
)